# Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

> **NCT00093678** · NA · WITHDRAWN · sponsor: **Eastern Cooperative Oncology Group**

## Conditions studied

- Cachexia
- Lymphoma
- Melanoma (Skin)
- Ovarian Cancer
- Pain
- Sarcoma
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** celecoxib
- **PROCEDURE:** anticachectic therapy
- **PROCEDURE:** nutritional support
- **PROCEDURE:** pain therapy
- **PROCEDURE:** supportive care/therapy

## Key facts

- **NCT ID:** NCT00093678
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093678, "Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00093678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*